Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Short term Debt: 2009-2024

Historic Short term Debt for Cumberland Pharmaceuticals (CPIX) over the last 3 years, with Dec 2024 value amounting to $5.1 million.

  • Cumberland Pharmaceuticals' Short term Debt was N/A to $5.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $5.1 million, marking a year-over-year change of. This contributed to the annual value of $5.1 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Cumberland Pharmaceuticals' Short term Debt is $5.1 million, which was up 91.25% from $2.7 million recorded in FY2010.
  • In the past 5 years, Cumberland Pharmaceuticals' Short term Debt registered a high of $5.1 million during FY2024, and its lowest value of $5.1 million during FY2024.
  • Over the past 1 years, Cumberland Pharmaceuticals' median Short term Debt value was $5.1 million (recorded in 2024), while the average stood at $5.1 million.